PTC Therapeutics Inc. (PTCT) Is Up Sharply On CHMP Opinion

By RTT News, 
A A A


(RTTNews.com) - PTC Therapeutics Inc. ( PTCT ) announced Friday morning that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna.

PTC Therapeutics gapped open dramatically higher Friday and is now up 12.19 at $27.51, with volume at a 3 1/2 month high. The stock has leaped to its highest level since early April.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: PTCT

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

113,590,482
  • $14.98 ▼ 1.77%
57,689,941
  • $94.67 ▼ 0.37%
51,501,990
  • $3.31 ▼ 2.07%
46,645,770
  • $96.13 ▲ 0.55%
42,212,567
  • $72.36 ▼ 0.40%
39,428,076
  • $25.35 ▲ 0.80%
36,799,747
    $37 unch
36,459,390
  • $44.13 ▼ 2.35%
As of 8/1/2014, 04:03 PM